0001209191-20-020912.txt : 20200324
0001209191-20-020912.hdr.sgml : 20200324
20200324161033
ACCESSION NUMBER: 0001209191-20-020912
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200315
FILED AS OF DATE: 20200324
DATE AS OF CHANGE: 20200324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moran Kevin Patrick
CENTRAL INDEX KEY: 0001806596
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34186
FILM NUMBER: 20738485
MAIL ADDRESS:
STREET 1: C/O VANDA PHARMACEUTICALS INC.
STREET 2: 2200 PENNSYLVANIA AVENUE, SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001347178
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030491827
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
BUSINESS PHONE: 202-734-3400
MAIL ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-03-15
0
0001347178
Vanda Pharmaceuticals Inc.
VNDA
0001806596
Moran Kevin Patrick
C/O VANDA PHARMACEUTICALS INC.
2200 PENNSYLVANIA AVENUE, SUITE 300E
WASHINGTON
DC
20037
0
1
0
0
VP, Acting CFO & Treasurer
Common Stock
14237
D
Common Stock
2532
D
Common Stock
12578
D
Common Stock
18750
D
Common Stock
12656
D
Common Stock
635
I
By Wife
Stock Option (Right to Buy)
7.94
2026-02-11
Common Stock
6750
D
Stock Option (Right to Buy)
12.27
2024-12-03
Common Stock
15000
D
Stock Option (Right to Buy)
11.59
2023-12-02
Common Stock
15000
D
Stock Option (Right to Buy)
3.12
2022-12-07
Common Stock
7500
D
Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest in full on March 1, 2021, provided the Reporting Person remains continuously employed by the Issuer through such vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
Represents shares of common stock underlying an RSU award. One-half of the RSU will vest on February 28, 2021, and the remaining one-half of the RSU will vest on February 28, 2022, provided the Reporting Person remains continuously employed by the Issuer through each vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
Represents shares of common stock underlying an RSU award. The RSU vests in three (3) equal annual installments with the first annual vest taking place on March 1, 2021, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
Represents shares of common stock underlying an RSU award. The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2021, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
The option is fully vested and immediately exercisable.
/s/ Kevin Patrick Moran
2020-03-24